Penetrable Nanoplatform for "Cold" Tumor Immune Microenvironment Reeducation.
Penetrable Nanoplatform for "Cold" Tumor Immune Microenvironment Reeducation.
复制标题
用于“冷”肿瘤免疫微环境再教育的可穿透纳米平台
DOI:
10.1002/advs.202000411
复制
发表时间:
2020-09
期刊:
影响因子:
--
通讯作者:
Jiang C
中科院分区:
文献类型:
--
作者:
Chen Q;He Y;Wang Y;Li C;Zhang Y;Guo Q;Zhang Y;Chu Y;Liu P;Chen H;Zhou Z;Zhou W;Zhao Z;Li X;Sun T;Jiang C
Lack of tumor‐infiltration lymphocytes (TILs) and resistances by overexpressed immunosuppressive cells (principally, myeloid‐derived suppressor cells (MDSCs)) in tumor milieu are two major challenges hindering the effectiveness of immunotherapy for “immune‐cold” tumors. In addition, the natural physical barrier existing in solid cancer also limits deeper delivery of drugs. Here, a tumor‐targeting and light‐responsive‐penetrable nanoplatform (Apt/PDGs^s@pMOF) is developed to elicit intratumoral infiltration of cytotoxic T cells (CTLs) and reeducate immunosuppressive microenvironment simultaneously. In particular, porphyrinic metal–organic framework (pMOF)–based photodynamic therapy (PDT) induces tumor immunogenic cell death (ICD) to promote CTLs intratumoral infiltration and hot “immune‐cold” tumor. Upon being triggered by PDT, the nearly 10 nm adsorbed drug‐loaded dendrimer de‐shields from the nanoplatform and spreads into the deeper tumor, eliminating MDSCs and reversing immunosuppression, eventually reinforcing immune response. Meanwhile, the designed nanoplatform also has a systemic MDSC inhibition effect and moderate improvement of overall antitumor immune responses, resulting in effective suppression of distal tumors within less significant immune‐related adverse effects (irAEs) induced. A penetrable nanoplatform is developed to elicit intratumoral infiltration of cytotoxic T cells (CTLs) and reeducate immunosuppressive microenvironment simultaneously. In particular, immunogenic cell death induced by photodynamic therapy (PDT) promotes CTLs infiltration, upon being triggered by PDT, drug‐loaded dendrimer spreads into deeper tumor, eliminating myeloid‐derived suppressor cells and reversing immunosuppression, eventually reinforcing immune responses.
登录
查看更多内容
DOI:
10.3322/caac.20114
发表时间:
2011-07
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者:
Golab J
影响因子:
14
作者:
Chen, Wei-Hai;Luo, Guo-Feng;Zhang, Xian-Zheng
通讯作者:
Zhang, Xian-Zheng
影响因子:
5
作者:
Cheng, Alan K. H.;Sen, Dipankar;Yu, Hua-Zhong
通讯作者:
Yu, Hua-Zhong
DOI:
10.1097/ppo.0000000000000006
发表时间:
2013-11
期刊:
Cancer journal (Sudbury, Mass.)
影响因子:
--
作者:
Albeituni SH;Ding C;Yan J
通讯作者:
Yan J
影响因子:
5.8
作者:
BOUFFARD, DY;LALIBERTE, J;MOMPARLER, RL
通讯作者:
MOMPARLER, RL